Literature DB >> 6687290

Hemolytic-uremic syndrome and T-cryptantigen exposure by neuraminidase-producing pneumococci: an emerging problem?

R W Novak, C R Martin, E N Orsini.   

Abstract

Hemolytic anemia, thrombocytopenia, and renal failure form a constellation of complications observed in patients infected with neuraminidase-producing pneumococci. The circulating enzyme causes exposure of the T-cryptantigen on cell surfaces to which most people possess a naturally occurring antibody. Antigen-antibody interaction activates effector systems that lead to the clinical manifestations. The syndrome is most frequently seen in infants, in whom it carries more than a 50% mortality rate. T-cryptantigen activation can be detected by demonstrating red cell agglutination by the peanut lectin Arachis hypogea. Plasma exchange and avoidance of blood products containing immunoglobins are of value in the management of this devastating complication of pneumococcal infection.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6687290     DOI: 10.3109/15513818309025872

Source DB:  PubMed          Journal:  Pediatr Pathol        ISSN: 0277-0938


  16 in total

Review 1.  Current views on aetiology and management of haemolytic uraemic syndrome.

Authors:  M M Fitzpatrick; M J Dillon
Journal:  Postgrad Med J       Date:  1991-08       Impact factor: 2.401

2.  Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome.

Authors:  Gema Ariceta; Nesrin Besbas; Sally Johnson; Diana Karpman; Daniel Landau; Christoph Licht; Chantal Loirat; Carmine Pecoraro; C Mark Taylor; Nicole Van de Kar; Johan Vandewalle; Lothar B Zimmerhackl
Journal:  Pediatr Nephrol       Date:  2008-09-18       Impact factor: 3.714

3.  Exposure of Thomsen-Friedenreich antigen in Streptococcus pneumoniae infection is dependent on pneumococcal neuraminidase A.

Authors:  Mamie T Coats; Trudy Murphy; James C Paton; Barry Gray; David E Briles
Journal:  Microb Pathog       Date:  2011-03-04       Impact factor: 3.738

Review 4.  Pathogenesis of the hemolytic uremic syndromes: current concepts.

Authors:  B S Kaplan; V V Vedaranayanan
Journal:  Indian J Pediatr       Date:  1988 Jul-Aug       Impact factor: 1.967

Review 5.  Current treatment of atypical hemolytic uremic syndrome.

Authors:  Bernard S Kaplan; Rebecca L Ruebner; Joann M Spinale; Lawrence Copelovitch
Journal:  Intractable Rare Dis Res       Date:  2014-05

6.  Hepatocellular injury in Streptococcus pneumoniae-associated hemolytic uremic syndrome in children.

Authors:  C G Pan; H E Leichter; S L Werlin
Journal:  Pediatr Nephrol       Date:  1995-12       Impact factor: 3.714

Review 7.  Recent advances in understanding the pathogenesis of the hemolytic uremic syndromes.

Authors:  B S Kaplan; T G Cleary; T G Obrig
Journal:  Pediatr Nephrol       Date:  1990-05       Impact factor: 3.714

8.  Effects of PspA and antibodies to PspA on activation and deposition of complement on the pneumococcal surface.

Authors:  Bing Ren; Alexander J Szalai; Susan K Hollingshead; David E Briles
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

9.  Haemolytic uraemic syndrome and the Thomsen Friedenreich antigen.

Authors:  M E McGraw; M Lendon; R F Stevens; R J Postlethwaite; C M Taylor
Journal:  Pediatr Nephrol       Date:  1989-04       Impact factor: 3.714

10.  Invasive Streptococcus pneumoniae infection causing hemolytic uremic syndrome in children: Two recent cases.

Authors:  Otto G Vanderkooi; James D Kellner; Andrew W Wade; Tajdin Jadavji; Julian P Midgley; Thomas Louie; Gregory J Tyrell
Journal:  Can J Infect Dis       Date:  2003-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.